NANOVIRICIDES, INC. Line of Credit Facility, Current Borrowing Capacity
NANOVIRICIDES, INC. (NNVC) had Line of Credit Facility, Current Borrowing Capacity of $3.00 million as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Notes
us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity · last filed 2026-05-15
- 2026-03-31: Line of Credit Facility, Current Borrowing Capacity $3.00M.
- 2025-12-31: Line of Credit Facility, Current Borrowing Capacity $3.00M.
- 2025-09-30: Line of Credit Facility, Current Borrowing Capacity $3.00M.
- 2025-06-30: Line of Credit Facility, Current Borrowing Capacity $3.00M.
| Period end | Line of Credit Facility, Current Borrowing Capacity |
|---|---|
| 2026-03-31 | $3.00M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $3.00M 10-Q · filed 2026-02-17 |
| 2025-09-30 | $3.00M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $3.00M 10-K · filed 2025-09-29 |
| 2025-03-31 | $3.00M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $3.00M 10-Q · filed 2025-02-14 |
| 2024-09-30 | $3.00M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $3.00M 10-K · filed 2024-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |